International Trade

  • March 20, 2008

    Injunction Against Qualcomm Chips Survives Appeal

    An appellate judge refused Tuesday to block a lower court's permanent injunction barring Qualcomm Inc. from importing and selling chips and devices that allegedly infringe three Broadcom Corp. patents.

  • March 20, 2008

    ITC Probes Sony In LED Patent Case

    The U.S. International Trade Commission has opened an investigation into whether more than 30 major electronics companies, including Sony Corp., infringed a Columbia University professor’s technology covering short-wavelength light-emitting diodes and laser diodes.

  • March 19, 2008

    Indian Court Nixes Roche's Bid To Bar Generic Tarceva

    Cipla received a boost on Wednesday when the High Court of Delhi reportedly refused to intercept the Indian generics maker's efforts to manufacture and market F. Hoffmann-La Roche Ltd.'s cancer drug Tarceva without a compulsory license.

  • March 19, 2008

    ITC Must Consider Amgen, Roche Dispute Over Mircera

    A federal appeals court has affirmed a ruling allowing Roche Holding AG to import its anemia drug Mircera into the U.S. as long as the company doesn't sell it. But the court disagrees with the International Trade Commission's position that the ITC doesn't have jurisdiction over the case.

  • March 13, 2008

    Compulsory License Battle Moves To Indian Court

    Heating up the controversy over compulsory licensing, the High Court of Delhi reportedly is set to consider whether Indian generics manufacturer Natco Pharma should be allowed to override patents on cancer drugs made by Pfizer Inc. and F. Hoffmann-La Roche Ltd.

  • March 10, 2008

    CSPC, Vietnam Agree To Closer Scrutiny Of Imports

    Seeking to rehabilitate its tarnished image, The U.S. Consumer Product Safety Commission has reached an agreement with the Vietnamese government to tighten oversight of items imported from Vietnam to the United States.

  • March 10, 2008

    Thailand Does About-Face On Cancer Drug Patents

    In a turnaround from recent promises to reconsider its aggressive stance on compulsory licenses, Thailand's new government has decided to override international patents on three cancer drugs under pressure from health activists and doctors.

  • March 10, 2008

    EU To Probe U.S. Ban On Internet Gambling

    The European Union has launched an investigation into U.S. online gambling laws, which European betting companies have complained are being selectively and unfairly enforced against them.

  • March 7, 2008

    Printing Press Infringement Claims Snag ITC's Interest

    The U.S. International Trade Commission has instituted an investigation into PressTek Inc.'s allegations that Israeli printing plate manufacturer VIM Technologies Ltd., its partner Hanita Coatings RCA Ltd. and four North American distributors are infringing patents for printing press technology.

  • March 6, 2008

    ITC To Look At Syngenta's Alleged Infringement

    The U.S. International Trade Commission announced last week that it will investigate whether Syngenta AG and its subsidiaries are infringing Sumimoto's patent on a chemical used in pesticides, responding to a request by Sumitomo Chemical Co. Ltd. and its subsidiary Valent USA Corp.

  • March 5, 2008

    India Implicates Nine Firms In Cement Cartel

    Ahead of an expected strengthening of India's antitrust guidelines, the country's competition watchdog is already flexing its muscles, finding nine cement manufacturers guilty of operating a price-fixing cartel in 2000 and 2001.

  • March 4, 2008

    U.S., EU Appeal To WTO On Chinese News Rules

    The U.S. and EU have filed for dispute settlement consultation with the World Trade Organization against China over regulations that restrict financial news sources in China.

  • March 3, 2008

    U.K. Court Hands Nokia A Win In Qualcomm Case

    Dealing Nokia Corp. its second international patent victory in recent months, a British court has ruled that rival Qualcomm Inc.'s claims of patent infringement against the Finnish mobile phone maker were invalid.

  • March 3, 2008

    GE Claims Mitsubishi Infringes Turbine Patents

    General Electric has filed a complaint with the U.S International Trade Commission alleging that Mitsubishi Heavy Industries Ltd. and two of its subsidiaries have infringed on GE's patents for wind turbine technology.

  • March 3, 2008

    More Tessera Patent Claims Rejected In Re-Exam

    The U.S. Patent and Trademark Office has rejected claims for the fourth of five chip-packaging patents asserted by Tessera Inc. against an array of microchip firms.

  • March 3, 2008

    ITC To Investigate Chinese Graphite Electrode Imports

    Finding that U.S. industry may be harmed by alleged dumping activities, the U.S. International Trade Commission voted unanimously on Saturday to continue investigating China's imports of small-diameter graphite electrodes.

  • February 29, 2008

    ITC To Weigh Sharp's Patent Claims V. Samsung

    The U.S. International Trade Commission has agreed to begin an investigation into patent infringement allegations filed by Sharp Corp. against its rival Samsung, a month after agreeing to consider similar claims by Samsung against Sharp.

  • February 28, 2008

    ITC Won't Review Ruling In Nokia, Qualcomm Fight

    The U.S. International Trade Commission will not review its initial decision that Nokia Corp.'s cell phone handsets do not infringe three of rival Qualcomm Inc.'s patents, Qualcomm announced on Wednesday.

  • February 27, 2008

    EU Guidelines Aim To Stabilize Financial Markets

    The European Commission put forth proposed guidelines on Wednesday aimed at making sovereign wealth funds more transparent, predictable and accountable in order to bring more stability to global financial markets.

  • February 27, 2008

    India Considers Overriding Cancer Drug Patents

    Entering the bullpen once again, India is taking up the issue of how to balance patent protection with patient need, with the country's patent office reportedly set to consider this week whether to override patents on cancer drugs made by Pfizer Inc. and Roche AG and to allow a generics maker to ship copycat versions to Nepal for distribution.